Amryt Pharma PLC logo

Amryt Pharma PLC - ADR

NEW
NAS:AMYT (UK)   ADR
(Delisted) $ 14.70 0 (0%) 09:42 AM EST
At Loss
P/B:
2.90
Market Cap:
$ 942.77M
Enterprise V:
$ 1.07B
Volume:
-
Avg Vol (2M):
573.29K
Volume:
-
At Loss
Avg Vol (2M):
573.29K

Business Description

Description
Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).
Name Current Vs Industry Vs History
Cash-To-Debt 0.39
Equity-to-Asset 0.44
Debt-to-Equity 0.66
Debt-to-EBITDA 2.41
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.44
Distress
Grey
Safe
Beneish M-Score -3.7
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 34.2

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % 111.16
12-1 Month Momentum % 88.24

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.57
Quick Ratio 0.94
Cash Ratio 0.58
Days Inventory 316.7
Days Sales Outstanding 53.73
Days Payable 324.68

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -91.1
Shareholder Yield % -3.12

Financials (Next Earnings Date:2024-11-03 Est.)

AMYT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AMYT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Amryt Pharma PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 243.621
EPS (TTM) ($) -0.3
Beta 0
Volatility % 102.71
14-Day RSI 0
14-Day ATR ($) 0.029847
20-Day SMA ($) 0
12-1 Month Momentum % 88.24
52-Week Range ($) 6.41 - 14.77
Shares Outstanding (Mil) 64.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Amryt Pharma PLC Filings

Filing Date Document Date Form
No Filing Data

Amryt Pharma PLC Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Amryt Pharma PLC Frequently Asked Questions

What is Amryt Pharma PLC(AMYT)'s stock price today?
The current price of AMYT is $14.70. The 52 week high of AMYT is $14.77 and 52 week low is $6.41.
When is next earnings date of Amryt Pharma PLC(AMYT)?
The next earnings date of Amryt Pharma PLC(AMYT) is 2024-11-03 Est..
Does Amryt Pharma PLC(AMYT) pay dividends? If so, how much?
Amryt Pharma PLC(AMYT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1